PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Hulse Murray sold 84,602 shares of the firm’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $44.16, for a total transaction of $3,736,024.32. Following the completion of the transaction, the chief executive officer directly owned 54,996,930 shares in the company, valued at $2,428,664,428.80. This trade represents a 0.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Wednesday, August 19th, Jason Hulse Murray sold 84,717 shares of PACS Group stock. The shares were sold at an average price of $44.26, for a total transaction of $3,749,574.42.
- On Tuesday, August 18th, Jason Hulse Murray sold 66,797 shares of PACS Group stock. The stock was sold at an average price of $44.18, for a total transaction of $2,951,091.46.
PACS Group Trading Up 1.0%
PACS opened at $44.24 on Thursday. PACS Group, Inc. has a fifty-two week low of $7.50 and a fifty-two week high of $49.49. The firm has a market capitalization of $7.00 billion, a PE ratio of 25.72, a P/E/G ratio of 1.24 and a beta of -0.08. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.91 and a quick ratio of 0.91. The company’s 50-day moving average is $43.20 and its 200 day moving average is $38.41.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on PACS. Zacks Research raised PACS Group from a “hold” rating to a “strong-buy” rating in a research report on Monday, August 10th. Royal Bank Of Canada raised their price objective on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, August 6th. Truist Financial lifted their price objective on shares of PACS Group from $52.00 to $62.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. UBS Group upped their target price on shares of PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Finally, Oppenheimer increased their target price on shares of PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $56.00.
Check Out Our Latest Report on PACS Group
Institutional Investors Weigh In On PACS Group
Several large investors have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp purchased a new position in shares of PACS Group in the second quarter worth about $8,196,000. Handelsbanken Fonder AB purchased a new stake in shares of PACS Group in the 2nd quarter valued at about $567,000. Financial Management Professionals Inc. raised its stake in PACS Group by 54.9% in the second quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock valued at $28,000 after purchasing an additional 235 shares in the last quarter. Empowered Funds LLC bought a new stake in shares of PACS Group during the 1st quarter worth $278,000. Finally, Western Wealth Management LLC purchased a new position in shares of PACS Group in the 1st quarter worth about $48,000.
About PACS Group
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Featured Stories
- Five stocks we like better than PACS Group
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
